August 29, 2018

Media

Media & events

Play Video
Play Video

PRESS RELEASES

2020

Lyndra Therapeutics Appoints George A. Eldridge as Chief Financial Officer – October 20, 2020

read more

Lyndra Therapeutics Achieves Critical Milestones Despite COVID-19 Headwinds – June 10, 2020

read more

Lyndra Therapeutics Files IND, Bolsters Leadership Team and Readies for Manufacturing – February 11, 2020

read more

2019

Lyndra Therapeutics to Develop Once-Monthly Oral Contraceptive – July 30, 2019

read more

Lyndra Therapeutics and Gilead Sciences to Collaborate on Development of Ultra-Long-Acting HIV Therapeutics – July 8, 2019

read more

Lyndra Therapeutics Welcomes Dr. Patricia Hurter as Chief Executive Officer – June 3, 2019

read more

Lyndra Therapeutics Takes on Opioid Use Disorder with Long-Acting Oral Dosage Form – April 9, 2019

read more

FUJIFILM Joins Lyndra Therapeutics’ Series B Raise, Bringing Total Round to $60 Million – February 11, 2019

read more

Lyndra Therapeutics Raises $55 Million in Series B Financing – January 29, 2019

read more

2018

Lyndra Therapeutics Announces Notice of Allowance on Patent Covering Long-acting Pill – December 10, 2018

read more

Lyndra Therapeutics Reports Positive Results from Pharmacokinetics (PK) Study of its Ultra-long-acting Oral Dosage Form – November 15, 2018

read more

Lyndra Announces Publication of Feasibility Study of Oral Once-Weekly Drug Delivery System for HIV Antiretroviral Therapy in Nature Communications – January 8, 2018

read more

2017

Lyndra, Inc. and Allergan Sign a Partnership to Develop Ultra-Long-Acting Oral Products – September 7, 2017

read more

Lyndra Secures Funding from the National Institute of Allergy and Infectious Diseases for the Development of Ultra-Long Acting Oral HIV Therapies – May 2, 2017

read more

Lyndra, Inc. Raises $23 Million in Series A Financing to Advance Ultra-Long Acting Oral Therapeutic Delivery – April 13, 2017

read more

2016

Lyndra Scientists Develop Ultra Long-Acting Oral Drug Delivery Platform – November 16, 2016

read more

PUBLICATIONS

2020

Ultra Long-Acting Oral Therapies for Alzheimer’s: Proof of Principle 2020 Alzheimer’s Association International Conference, July 2020

read more

Becoming the CEO – Life Sciences Leader, May 2020

read more

2019

A once-a-month oral contraceptive – Science Translational Medicine, December 2019

read more

A pharmaceutical answer to non-adherence: Once weekly oral memantine for Alzheimer’s disease – Journal of Controlled Release, June 2019

read more

2018

Changing the Pill: Developments Toward the Promise of an Ultra-Long-Acting Gastroretentive Dosage Form – Expert Opinion on Drug Delivery, November 2018

read more

Development of an Oral Once-Weekly Drug Delivery System for HIV Antiretroviral Therapy – Nature Communications, January 2018

read more

2016

Oral, ultra–long-lasting drug delivery: Application toward malaria elimination goals – Science Translational Medicine, November 2016

read more

Lyndra White Paper on Adherence to Medication – White Paper on Adherence to Medication, September 2016

read more

news

2020

Birth Control Pill Of The Future May Only Need To Be Taken Once A Month – WBUR | August 30, 2020

read more

Weekly Pill Formulation Could Help Treat Schizophrenia, HIV, Malaria and more – National Institutes of Health, Small Business Innovation Research | August 25, 2020

read more

Running the Operations of a Biotech Company That’s Transforming Oral Drug DeliveryPartnership Opportunities in Drug Delivery newsletter’s – Women Leadership in Drug Delivery Issue | July 16, 2020

read more

Changing the Pill: Tackling Medication Adherence Through Innovative TechnologyNational Center for Advancing Translational Sciences (NCATS) | March 17, 2020

read more

How Swallowing a Star Might Keep You From Missing a Dose of MedicineBoston Globe | January 31, 2020

read more

Watertown startup unveils it’s new starBoston Globe | January 16, 2020

read more

JPM: 4 women discuss culture shock between Big Pharma, smaller biotech and their first CEO role – FierceBiotech | January 16, 2020

read more

JPM: ‘An embarrassment of riches’—Lyndra CEO Hurter on the promise of ultralong-acting pillsFierceBiotech | January 16, 2020

read more

2019

Once-a-month contraceptive pill developed by scientistsThe Guardian | December 6, 2019

read more

Researchers Make Progress Toward a Monthly Birth Control PillTime | December 6, 2019

read more

Once-a-month birth control pill? Experiment works in animalsAP News | December 6, 2019

read more

A Once-a-Month Birth Control Pill Is Coming—Here’s How It Works – Wired | December 5, 2019

read more

MIT researchers are developing a once-a-month birth control pill – Boston Globe | December 5, 2019

read more

Lyndra Pursues Once-a-Month Oral Contraceptive with $13M Gates Foundation Grant – Genetic Engineering and Biotechnology News | July 30, 2019

read more

Gates backs development work on a long-acting contraceptive pill Endpoints  | July 30, 2019

read more

Lyndra, Gates Foundation team up on once-a-month birth control Boston Business Journal | July 30, 2019

read more

This company wants to make a once-a-month option for birth control pills – STAT | July 30, 2019

read more

Lyndra Therapeutics bags $13M Gates grant to develop once-monthly contraceptive pill – FierceBiotech | July 30, 2019

read more

Watertown biotech Lyndra teams up with Gilead in $15m deal to treat HIV – Boston Globe | July 9, 2019

read more

Gilead pays Watertown startup Lyndra $123M to develop longer-lasting HIV pill – Boston Business Journal | July 9, 2019

read more

Ex-Vertex Pharma Exec Patricia Hurter to Join Lyndra as CEO – Xconomy | June 5, 2019

read more

Lyndra Therapeutics’ incoming CEO is used to running tough races – Boston Globe | June 3, 2019

read more

Watertown biotech Lyndra snags longtime Vertex exec as CEO – Boston Business Journal | June 3, 2019

read more

Lyndra Announces Feasibility Study of Oral Once-Weekly HIV Drug – Daily Mail | January 9, 2019

read more

2018

Sick of a daily pill? A Boston biotech wants to make a daily Alzheimer’s drug last for a week — and they’re working on more – STAT | November 15, 2018

read more

Watertown biotech plans first clinical trial of weeklong schizophrenia drug – Boston Business Journal | November 15, 2018

read more

A Gates Foundation-Backed Startup Wants to Make Daily Pills a Thing of the Past – Business Insider | February 2, 2018

read more

Once-a-Week Pill for HIV – BBC | January 9, 2018

read more

Drug Capsule May Allow Weekly HIV Treatment European Pharmaceutical Review | January 9, 2018

read more

Swallowing A ‘Mini-Pillbox’ Could Change The Way HIV Drugs Are Delivered NPR | January 9, 2018

read more

2017

Alzheimer’s: Treating with a Daily Pill in the Future? Fox Business News | September 7, 2017

read more

Watertown’s Lyndra Strikes Alzheimer’s Pact with Allergan Worth up to $105M Boston Business Journal | September 7, 2017

read more

Watertown’s Lyndra Nabs $23M to Bankroll Long-Lasting Pill Tech Boston Business Journal | April 13, 2017

read more

Lyndra’s Long-Acting Drug Delivery Technology Lands $23M InvestmentXconomy | April 13, 2017

read more

Lyndra Raises $23M in Series A to Progress Ultra-Long-Acting Oral Drug Delivery TechGenetic Engineering & Biotechnology News | April 13, 2017

read more

Lyndra Raises $23M in Series A to Progress Ultra-Long-Acting Oral Drug Delivery TechGenetic Engineering & Biotechnology News | April 13, 2017

read more

2016

‘Ultra-Long-Acting’ Pill Delivers Malaria Drug for 14 DaysFierceBiotech | November 16, 2016

read more

How a Small Watertown Biotech is Trying to Make Oral Drugs Last LongerBoston Business Journal | November 16, 2016

read more

Long-Lasting Pill to Replace Daily DoseThe Times | November 16, 2016

read more

Long-Lasting Pill that Releases Malaria Drug for Two Weeks a ‘Game-Changer’The Guardian| November 16, 2016

read more